Prof. Mohamad Mohty – Multiple myeloma take home messages from ASCO 2021 By Adam Barkay|2021-06-15T21:23:13+00:00June 15th, 2021|All, ASCO 2021|Comments Off on Prof. Mohamad Mohty – Multiple myeloma take home messages from ASCO 2021 Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkEmail About the Author: Adam Barkay Related Posts Dr. Doris Hansen- Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium Dr. Doris Hansen- Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium Prof. Florent Malard- The First microbiota therapy approved by the US FDA Prof. Florent Malard- The First microbiota therapy approved by the US FDA Prof. Marion Subklewe- T-cell exhaustion induced by continuous bispecific molecule exposure Prof. Marion Subklewe- T-cell exhaustion induced by continuous bispecific molecule exposure Prof. Mohamad Mohty – FDA Breakthrough Therapy Designation for Elranatamab in Relapsed or Refractory Multiple Myeloma Prof. Mohamad Mohty – FDA Breakthrough Therapy Designation for Elranatamab in Relapsed or Refractory Multiple Myeloma Dr. Eolia Brissot – Positive opinion of the CHMP on tabelecleucel for the treatment of Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease Dr. Eolia Brissot – Positive opinion of the CHMP on tabelecleucel for the treatment of Epstein-Barr Virus-Positive Post-Transplant Lymphoproliferative Disease
